BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2559522)

  • 1. Activity of rifabutin alone and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium intracellulare infections in mice.
    Saito H; Sato K
    Tubercle; 1989 Sep; 70(3):201-5. PubMed ID: 2559522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of rifabutin alone or in combination with clofazimine or ethambutol or both against acute and chronic experimental Mycobacterium intracellulare infections.
    Gangadharam PR; Perumal VK; Jairam BT; Rao PN; Nguyen AK; Farhi DC; Iseman MD
    Am Rev Respir Dis; 1987 Aug; 136(2):329-33. PubMed ID: 3039879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients.
    Hoy J; Mijch A; Sandland M; Grayson L; Lucas R; Dwyer B
    J Infect Dis; 1990 Apr; 161(4):801-5. PubMed ID: 2156947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo activities of newer rifamycin analogs against Mycobacterium avium infection.
    Klemens SP; Cynamon MH
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2026-30. PubMed ID: 1662021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice.
    Yamamoto T; Amitani R; Suzuki K; Tanaka E; Murayama T; Kuze F
    Antimicrob Agents Chemother; 1996 Feb; 40(2):429-32. PubMed ID: 8834892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice.
    Gangadharam PR; Perumal VK; Podapati NR; Kesavalu L; Iseman MD
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1400-3. PubMed ID: 2848444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice.
    Saito H; Tomioka H; Sato K; Kawahara S; Hidaka T; Dekio S
    Tuber Lung Dis; 1995 Feb; 76(1):51-8. PubMed ID: 7718848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. The Rifabutin Treatment Group.
    Sullam PM; Gordin FM; Wynne BA
    Clin Infect Dis; 1994 Jul; 19(1):84-6. PubMed ID: 7948562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunist mycobacteria. Groupe d'Etude et de Traitement des Infections à Mycobacteries Résistantes.
    Dautzenberg B; Truffot C; Mignon A; Rozenbaum W; Katlama C; Perronne C; Parrot R; Grosset J
    Tubercle; 1991 Sep; 72(3):168-75. PubMed ID: 1663282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of triple drug regimen of amikacin, ethambutol and rifabutin in AIDS patients with symptomatic Mycobacterium avium complex infection.
    Jorup-Rönström C; Julander I; Petrini B
    J Infect; 1993 Jan; 26(1):67-70. PubMed ID: 8384230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress report: prophylaxis and therapy for MAC.
    Currier J
    AIDS Clin Care; 1996 Jun; 8(6):45-8. PubMed ID: 11363599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine.
    Field SK; Cowie RL
    Chest; 2003 Oct; 124(4):1482-6. PubMed ID: 14555583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS.
    Agins BD; Berman DS; Spicehandler D; el-Sadr W; Simberkoff MS; Rahal JJ
    J Infect Dis; 1989 Apr; 159(4):784-7. PubMed ID: 2926169
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
    Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
    Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of the body burden of M. avium complex is associated with improved quality of life and prolonged survival of patients with AIDS: a prospective trial with rifabutin combined with isoniazid, clofazimine, ethambutol.
    Olliaro P; Dautzenberg B
    J Chemother; 1994 Jun; 6(3):189-96. PubMed ID: 7983502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
    Chaisson RE; Keiser P; Pierce M; Fessel WJ; Ruskin J; Lahart C; Benson CA; Meek K; Siepman N; Craft JC
    AIDS; 1997 Mar; 11(3):311-7. PubMed ID: 9147422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial.
    Zweijpfenning SMH; Aarnoutse R; Boeree MJ; Magis-Escurra C; Stemkens R; Geurts B; van Ingen J; Hoefsloot W
    Chest; 2024 May; 165(5):1082-1092. PubMed ID: 38040054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of
    Lanoix JP; Joseph C; Peltier F; Castelain S; Andréjak C
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.